Data from Epidermal Growth Factor Receptor Mutants from Human Lung Cancers Exhibit Enhanced Catalytic Activity and Increased Sensitivity to Gefitinib
Roseann Mulloy(Harvard University), Jeffrey Settleman(Enzo Life Sciences (United States)), Daphne W. Bell(National Institutes of Health), Karen S. Anderson(Arizona State University), Raffaella Sordella(Cold Spring Harbor Laboratory), Audrey Ferrand(Université Toulouse III - Paul Sabatier), Youngjoo Kim, Daniel A. Haber(Howard Hughes Medical Institute)
Cited by 0
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k